BrightFocus 2013-14 grantee Crystal Miller, PhD, and her mentor, Bruce Lamb, PhD, both of the Cleveland Clinic, along with Taylor Jay of Case Western Reserve University, are coauthors on a new report that describes the surprising—even counterintuitive--role that a genetic variant associated with the immune system plays in Alzheimer’s disease (AD).
The 2015 Academy Awards telecast shed a light on the diseases BrightFocus is battling—Alzheimer's disease and the vision diseases associated with aging that altogether affect tens of millions of Americans.
An international research collaboration has uncovered some clues to macular degeneration’s onset, namely, the discovery of a microscopic mineral “scaffolding” around which drusen deposits—a hallmark sign of the early stages of age-related macular degeneration (AMD)—begin to form.
Congratulations to Julianne Moore, star of “Still Alice,” on her “Best Actress” award at the Golden Globes. The film, which opens January 16, portrays the struggle of a college linguistics professor who experiences early Alzheimer’s.
In the January 2015 issue of Lancet Neurology, Randall Bateman, MD, reviews top achievements in Alzheimer’s research in 2014. A long-time colleague of BrightFocus and one of our current grantees, Bateman is the Charles F. and Joanne Knight Distinguished Professor of Neurology at the Washington University of St. Louis Medical School.
A new study suggests that many people with AMD may not be getting their treatment benefits—or their money’s worth—from their ocular vitamins. It turns out that many of the products being marketed may not contain identical ingredient dosages to the AREDS and AREDS2 formulas.
More than 250 science journalists covered the Society for Neuroscience meeting in Washington, DC, this week. Two close colleagues of BrightFocus took part in press conferences to explain new directions in Alzheimer’s research.
A leading government science officer addressed BrightFocus grantees attending our annual breakfast sponsored during the Society for Neuroscience (SfN) meeting, which was held in Washington, DC, this week.
November 19, 2014
Donate to Cure Brain and Eye Diseases
Help end Alzheimer's, Macular Degeneration, and Glaucoma